Loading...

Ishwarlal Jialal

TitleProf
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lent-Schochet D, Silva R, McLaughlin M, Huet B, Jialal I. Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome. Horm Mol Biol Clin Investig. 2018 Apr 18. PMID: 29668463.
      View in: PubMed
    2. Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri SK, Jialal I. Correction to: Inflammation, Atherosclerosis, and Psoriasis. Clin Rev Allergy Immunol. 2018 Mar 19. PMID: 29557054.
      View in: PubMed
    3. Reddy P, Leong J, Jialal I. Amino acid levels in nascent metabolic syndrome: A contributor to the pro-inflammatory burden. J Diabetes Complications. 2018 May; 32(5):465-469. PMID: 29559272.
      View in: PubMed
    4. Jialal I, Jialal G, Devaraj S, Adams-Huet B. The effect of increasing tertiles of waist circumference on cardio-metabolic risk, adipokines and biomarkers of inflammation and oxidative stress in nascent metabolic syndrome. J Diabetes Complications. 2018 Apr; 32(4):379-383. PMID: 29478813.
      View in: PubMed
    5. Jialal I, Devaraj S. Subcutaneous adipose tissue biology in metabolic syndrome. Horm Mol Biol Clin Investig. 2018 Jan 20; 33(1). PMID: 29353263.
      View in: PubMed
    6. Pahwa R, Balderas M, Jialal I, Chen X, Luna RA, Devaraj S. Gut Microbiome and Inflammation: A Study of Diabetic Inflammasome-Knockout Mice. J Diabetes Res. 2017; 2017:6519785. PMID: 29435463.
      View in: PubMed
    7. Jialal I, Vikram NK. Inflammation and atherosclerosis: fulfilling Koch's postulates. Ther Adv Cardiovasc Dis. 2018 Jan; 12(1):5-6. PMID: 29187060.
      View in: PubMed
    8. Furman A, Jialal I. Excessive hypercortisolemia due to ectopic Cushing's syndrome requiring extending the reportable range for plasma cortisol for management. Clin Chem Lab Med. 2017 Nov 27; 56(1):e7-e9. PMID: 28672733.
      View in: PubMed
    9. Jialal I, Gounden V. Reporting LDL-cholesterol levels in the era of intensive lipid management: a clarion call. Clin Chem Lab Med. 2017 08 28; 55(10):1447-1449. PMID: 28796640.
      View in: PubMed
    10. Jialal I, Pahwa R, Adams-Huet B, Siegel D. Normal uric acid levels in nascent metabolic syndrome patients residing in northern California. J Diabetes Complications. 2017 Nov; 31(11):1639-1640. PMID: 28899611.
      View in: PubMed
    11. Jialal I, Inn M, Siegel D, Devaraj S. Underestimation of Low Density Lipoprotein-Cholesterol With the Friedewald Equation Versus a Direct Homogenous Low Density Lipoprotein-Cholesterol Assay. Lab Med. 2017 Aug 01; 48(3):220-224. PMID: 28398496.
      View in: PubMed
    12. Jialal I, Camacho F, Nathoo B, Tam P, Pahwa R, Wu GG. Fibroblast Growth Factor 23 Predicts Mortality and End-Stage Renal Disease in a Canadian Asian Population with Chronic Kidney Disease. Nephron. 2017; 137(3):190-196. PMID: 28743129.
      View in: PubMed
    13. Jialal I, Vikram N. Nutrition therapy for diabetes: Implications for decreasing cardiovascular complications. J Diabetes Complications. 2017 Oct; 31(10):1477-1480. PMID: 28830659.
      View in: PubMed
    14. Jialal I. Interpretation of protein electrophoresis. Ann Clin Biochem. 2017 09; 54(5):622. PMID: 28504608.
      View in: PubMed
    15. Pahwa R, Adams-Huet B, Jialal I. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome. J Diabetes Complications. 2017 May; 31(5):810-813. PMID: 28285929.
      View in: PubMed
    16. Jialal I, Pahwa R. Quantification of daratumumab in the serum protein electrophoresis. Clin Chem Lab Med. 2017 Feb 01; 55(2):e27-e28. PMID: 27718485.
      View in: PubMed
    17. Rajamani U, Jialal I. Erratum to "Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy". J Diabetes Res. 2016; 2016:8976945. PMID: 27965985.
      View in: PubMed
    18. Duell PB, Jialal I. Modern Management of Familial Hypercholesterolemia. Metab Syndr Relat Disord. 2016 12; 14(10):463-467. PMID: 27797643.
      View in: PubMed
    19. Swislocki AL, Jialal I. Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study. Metab Syndr Relat Disord. 2016 10; 14(8):375-377. PMID: 27552667.
      View in: PubMed
    20. Datta Mitra A, Gupta A, Jialal I. Folate Insufficiency Due to Celiac Disease in a 49-Year-Old Woman of Southeast Asian-Indian Ethnicity. Lab Med. 2016 Aug; 47(3):259-62. PMID: 27406144; PMCID: PMC4985778 [Available on 08/01/17].
    21. Jialal I, Adams-Huet B, Devaraj S. Factors that promote macrophage homing to adipose tissue in metabolic syndrome. J Diabetes Complications. 2016 Nov - Dec; 30(8):1434-1436. PMID: 27557909.
      View in: PubMed
    22. Rosenberg AS, Bainbridge S, Pahwa R, Jialal I. Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay. Clin Biochem. 2016 Oct; 49(15):1202-1204. PMID: 27475249.
      View in: PubMed
    23. Jialal I, Dhindsa S. Hypoglycemia and the predisposition to cardiovascular disease: Is the pro-inflammatory-pro-coagulant diathesis a plausible explanation? Atherosclerosis. 2016 Aug; 251:504-506. PMID: 27318869.
      View in: PubMed
    24. Pahwa R, Jialal I. Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress. Metab Syndr Relat Disord. 2016 06; 14(5):239-41. PMID: 27105077.
      View in: PubMed
    25. Devaraj S, Jialal I. The skinny on metabolic syndrome in adolescents. Transl Pediatr. 2016 Apr; 5(2):97-9. PMID: 27186529; PMCID: PMC4855191.
    26. Pahwa R, Jialal I. The role of the high-mobility group box1 protein-Toll like receptor pathway in diabetic vascular disease. J Diabetes Complications. 2016 Aug; 30(6):1186-91. PMID: 27037040.
      View in: PubMed
    27. Devaraj S, Jialal I. The Paradox of Increased Trimethylamine-N-Oxide Levels Following Bariatric Surgery. Metab Syndr Relat Disord. 2016 May; 14(4):195-6. PMID: 26958935.
      View in: PubMed
    28. Jialal I, Barton Duell P. Diagnosis of Familial Hypercholesterolemia. Am J Clin Pathol. 2016 Apr; 145(4):437-9. PMID: 27114384.
      View in: PubMed
    29. Santos-Gallego CG, Jialal I. Cadmium and atherosclerosis: Heavy metal or singing the blues? Atherosclerosis. 2016 Jun; 249:230-2. PMID: 27012656.
      View in: PubMed
    30. Butani L, Dharmar M, Devaraj S, Jialal I. Preliminary Report of Inflammatory Markers, Oxidative Stress, and Insulin Resistance in Adolescents of Different Ethnicities. Metab Syndr Relat Disord. 2016 Apr; 14(3):182-6. PMID: 26824677.
      View in: PubMed
    31. Pahwa R, Nallasamy P, Jialal I. Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx. J Diabetes Complications. 2016 May-Jun; 30(4):563-72. PMID: 26908090.
      View in: PubMed
    32. Jialal I, Adams-Huet B, Devaraj S. Monocyte cell adhesion molecule receptors in nascent metabolic syndrome. Clin Biochem. 2016 Apr; 49(6):505-507. PMID: 26724276.
      View in: PubMed
    33. Swislocki AL, Jialal I. Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest? Metab Syndr Relat Disord. 2016 Feb; 14(1):3-6. PMID: 26677930.
      View in: PubMed
    34. Jialal I, Devaraj S, Adams-Huet B. Plasma fetuin-A does not correlate with monocyte TLR4 in humans. Diabetologia. 2016 Jan; 59(1):222-3. PMID: 26585510.
      View in: PubMed
    35. Devaraj S, Adams-Huet B, Jialal I. Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome. Metab Syndr Relat Disord. 2015 Dec; 13(10):477-80. PMID: 26505293.
      View in: PubMed
    36. Jialal I, Adams-Huet B, Pahwa R. Selective increase in monocyte p38 mitogen-activated protein kinase activity in metabolic syndrome. Diab Vasc Dis Res. 2016 Jan; 13(1):93-6. PMID: 26449239.
      View in: PubMed
    37. Pahwa R, Jialal I. Cellular Signaling in Metabolic Syndrome. Metab Syndr Relat Disord. 2015 Nov; 13(9):371-2. PMID: 26441015.
      View in: PubMed
    38. Jialal I, Abate N. Ezetimibe-Statin Combination to Reduce Cardiovascular Events: The Evidence Base. Metab Syndr Relat Disord. 2015 Oct; 13(8):327-8. PMID: 26177147.
      View in: PubMed
    39. Jialal I, Rashidi HH, Sokoll LJ. The Authors' Reply. Am J Clin Pathol. 2015 Jul; 144(1):174. PMID: 26263572.
      View in: PubMed
    40. Jialal I, Devaraj S, Bettaieb A, Haj F, Adams-Huet B. Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome. Atherosclerosis. 2015 Jul; 241(1):130-7. PMID: 25978344.
      View in: PubMed
    41. Swislocki AL, Jialal I. The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors. Metab Syndr Relat Disord. 2015 Sep; 13(7):287-91. PMID: 25893855.
      View in: PubMed
    42. Jialal I, Pahwa R. The evolving role of toll-like receptors in diabetic vascular complications. J Diabetes Complications. 2015 Jul; 29(5):617-20. PMID: 25935862.
      View in: PubMed
    43. Jialal I, Patel SB. PCSK9 inhibitors: the next frontier in low-density lipoprotein lowering. Metab Syndr Relat Disord. 2015 Apr; 13(3):99-101. PMID: 25734961.
      View in: PubMed
    44. Jialal I, Sokoll LJ. Clinical utility of lactate dehydrogenase: a historical perspective. Am J Clin Pathol. 2015 Feb; 143(2):158-9. PMID: 25596240.
      View in: PubMed
    45. Rajamani U, Jialal I. Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy. J Diabetes Res. 2014; 2014:790902. PMID: 25610879; PMCID: PMC4293793.
    46. Arzamendi AE, Rajamani U, Jialal I. Pseudoinsulinoma in a white man with autoimmune hypoglycemia due to anti-insulin antibodies: value of the free C-Peptide assay. Am J Clin Pathol. 2014 Nov; 142(5):689-93. PMID: 25319986.
      View in: PubMed
    47. Jialal I, Rajamani U. Endotoxemia of metabolic syndrome: a pivotal mediator of meta-inflammation. Metab Syndr Relat Disord. 2014 Nov; 12(9):454-6. PMID: 25162769.
      View in: PubMed
    48. Adams-Huet B, Devaraj S, Siegel D, Jialal I. Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines. Metab Syndr Relat Disord. 2014 Dec; 12(10):503-7. PMID: 25162912.
      View in: PubMed
    49. Jialal I, Major AM, Devaraj S. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. J Diabetes Complications. 2014 Nov-Dec; 28(6):755-61. PMID: 25116192.
      View in: PubMed
    50. Jialal I. What is the role of the clinical laboratory in the new ACC/AHA guidelines for the treatment of blood cholesterol in adults? Am J Clin Pathol. 2014 Jun; 141(6):772-3. PMID: 24838319.
      View in: PubMed
    51. Vikram NK, Jialal I. Use of HbA1c in the diagnosis of diabetes and prediabetes: sensitivity versus specificity. Metab Syndr Relat Disord. 2014 Jun; 12(5):255-7. PMID: 24716577.
      View in: PubMed
    52. Jialal I, Adams-Huet B, Duong F, Smith G. Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation. Metab Syndr Relat Disord. 2014 May; 12(4):227-30. PMID: 24593134.
      View in: PubMed
    53. Jialal I, Dhindsa S. No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: potential explanations. Metab Syndr Relat Disord. 2014 Apr; 12(3):157-8. PMID: 24520851.
      View in: PubMed
    54. Jialal I, Devaraj S. Comment on Lopes-Virella et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes care 2013;36:2317-2323. Diabetes Care. 2014 May; 37(5):e106-7. PMID: 24496802; PMCID: PMC3994940.
    55. Dhindsa S, Jialal I. Potential anti-atherosclerotic effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus. Curr Diab Rep. 2014 Feb; 14(2):463. PMID: 24390468.
      View in: PubMed
    56. Jialal I, Kaur H, Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab. 2014 Jan; 99(1):39-48. PMID: 24187406.
      View in: PubMed
    57. Jialal I, Kaur H, Devaraj S, Smith G. Human C-reactive protein induces endothelial dysfunction in biobreeding diabetic rats. Diab Vasc Dis Res. 2013 Nov; 10(6):550-3. PMID: 24028935.
      View in: PubMed
    58. Devaraj S, Chen X, Adams-Huet B, Jialal I. Increased expression of Fc-? receptors on monocytes in patients with nascent metabolic syndrome. J Clin Endocrinol Metab. 2013 Sep; 98(9):E1510-5. PMID: 23902948.
      View in: PubMed
    59. Dasu MR, Jialal I. Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice. J Diabetes Complications. 2013 Sep-Oct; 27(5):417-21. PMID: 23773694; PMCID: PMC3770740.
    60. Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. J Obes. 2013; 2013:393192. PMID: 23653857; PMCID: PMC3638696.
    61. Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri SK, Jialal I. Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol. 2013 Apr; 44(2):194-204. PMID: 22359071.
      View in: PubMed
    62. Sheely D, Jialal I. Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk. Metab Syndr Relat Disord. 2013 Jun; 11(3):149-51. PMID: 23496028.
      View in: PubMed
    63. Devaraj S, Chien A, Rao B, Chen X, Jialal I. Modulation of endothelial progenitor cell number and function with n-3 polyunsaturated fatty acids. Atherosclerosis. 2013 May; 228(1):94-7. PMID: 23528830.
      View in: PubMed
    64. Kumaresan PR, Devaraj S, Huang W, Lau EY, Liu R, Lam KS, Jialal I. Synthesis and characterization of a novel inhibitor of C-reactive protein-mediated proinflammatory effects. Metab Syndr Relat Disord. 2013 Jun; 11(3):177-84. PMID: 23445482; PMCID: PMC3848264.
    65. Winter WE, Jialal I, Devaraj S. Thyrotropin receptor antibody assays: clinical utility. Am J Clin Pathol. 2013 Feb; 139(2):140-2. PMID: 23355197.
      View in: PubMed
    66. Kaur H, Adams-Huet B, Smith G, Jialal I. Increased neutrophil count in nascent metabolic syndrome. Metab Syndr Relat Disord. 2013 Apr; 11(2):128-31. PMID: 23316866.
      View in: PubMed
    67. Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer AA. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013 Mar; 98(3):E514-7. PMID: 23303213.
      View in: PubMed
    68. Jialal I, Bajaj M. DPP-4 inhibitors and atherosclerosis: the promise. Atherosclerosis. 2013 Apr; 227(2):224-5. PMID: 23395524.
      View in: PubMed
    69. Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, Jia Q. Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord. 2013 Feb; 11(1):35-40. PMID: 23035844.
      View in: PubMed
    70. Kaur H, Chien A, Jialal I. Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol. 2012 Oct 15; 303(8):F1145-50. PMID: 22874765; PMCID: PMC3469679.
    71. Jialal I, Devaraj S, Adams-Huet B, Chen X, Kaur H. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. J Clin Endocrinol Metab. 2012 Oct; 97(10):E1844-50. PMID: 22872691.
      View in: PubMed
    72. Jialal I, Devaraj S. Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats. Diab Vasc Dis Res. 2012 Oct; 9(4):315-9. PMID: 22801596; PMCID: PMC3523880.
    73. Dhindsa S, Jialal I. Bariatric surgery for the metabolic syndrome: magic bullet or not? Metab Syndr Relat Disord. 2012 Aug; 10(4):241-3. PMID: 22737997.
      View in: PubMed
    74. Jialal I, Devaraj S. Circulating versus cellular biomarkers of inflammation in Type 1 diabetes: the superiority of C-reactive protein. Cytokine. 2012 Oct; 60(1):318-20. PMID: 22683005.
      View in: PubMed
    75. Jialal I, Smith G. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy. Metab Syndr Relat Disord. 2012 Jun; 10(3):159-60. PMID: 22568574.
      View in: PubMed
    76. Jialal I, Kaur H, Devaraj S. Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats. J Diabetes Complications. 2013 Jan-Feb; 27(1):23-8. PMID: 22520400; PMCID: PMC3404262.
    77. Swislocki AL, Siegel D, Jialal I. Pharmacotherapy for the metabolic syndrome. Curr Vasc Pharmacol. 2012 Mar; 10(2):187-205. PMID: 22022773.
      View in: PubMed
    78. Devaraj S, Syed B, Chien A, Jialal I. Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease. Am J Clin Pathol. 2012 Mar; 137(3):479-85. PMID: 22338062.
      View in: PubMed
    79. Jialal I, Huet BA, Kaur H, Chien A, Devaraj S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012 Apr; 35(4):900-4. PMID: 22357188; PMCID: PMC3308307.
    80. Jialal I, Kaur H. The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications. Curr Diab Rep. 2012 Feb 08. PMID: 22314791.
      View in: PubMed
    81. Jialal I. The tenth anniversary of metabolic syndrome and related disorders. Metab Syndr Relat Disord. 2012 Feb; 10(1):1-2. PMID: 22149901.
      View in: PubMed
    82. Devaraj S, Kumaresan PR, Jialal I. C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction. Clin Chem. 2011 Dec; 57(12):1757-61. PMID: 21980169.
      View in: PubMed
    83. Devaraj S, Jialal I. Dysfunctional endothelial progenitor cells in metabolic syndrome. Exp Diabetes Res. 2012; 2012:585018. PMID: 21941528; PMCID: PMC3176409.
    84. Bremer AA, Devaraj S, Afify A, Jialal I. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1782-8. PMID: 21865369; PMCID: PMC3205887.
    85. Yun JM, Chien A, Jialal I, Devaraj S. Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J Nutr Biochem. 2012 Jul; 23(7):699-705. PMID: 21813271; PMCID: PMC3209497.
    86. Jialal I, Devaraj S. Laboratory diagnosis of ethylene glycol poisoning: the cup is half full? Am J Clin Pathol. 2011 Aug; 136(2):165-6. PMID: 21757590.
      View in: PubMed
    87. Jialal I, Kaur J. The cholesterol ester transfer protein inhibitor, anacetrapib. Curr Opin Lipidol. 2011 Jun; 22(3):245-6. PMID: 21562390.
      View in: PubMed
    88. Devaraj S, Tobias P, Kasinath BS, Ramsamooj R, Afify A, Jialal I. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol. 2011 Aug; 31(8):1796-804. PMID: 21617141; PMCID: PMC3148786.
    89. Jialal I, Devaraj S, Siegel D. CRP induces hypertension in animal models: homo sapiens says no. Hypertens Res. 2011 Jul; 34(7):801-2. PMID: 21593738.
      View in: PubMed
    90. Devaraj S, Jialal I. Novel cholesteryl ester transfer protein inhibitors: promising therapy for dyslipidemia? Metab Syndr Relat Disord. 2011 Jun; 9(3):163-5. PMID: 21557663.
      View in: PubMed
    91. Devaraj S, Tobias P, Jialal I. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine. 2011 Sep; 55(3):441-5. PMID: 21498084.
      View in: PubMed
    92. Devaraj S, Jialal I, Rockwood J, Zak D. Effect of orange juice and beverage with phytosterols on cytokines and PAI-1 activity. Clin Nutr. 2011 Oct; 30(5):668-71. PMID: 21477901.
      View in: PubMed
    93. Devaraj S, Jialal I. C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Arterioscler Thromb Vasc Biol. 2011 Jun; 31(6):1397-402. PMID: 21415385; PMCID: PMC3099471.
    94. Devaraj S, Yun JM, Duncan-Staley CR, Jialal I. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am J Clin Pathol. 2011 Mar; 135(3):429-33. PMID: 21350098.
      View in: PubMed
    95. Devaraj S, Siegel D, Jialal I. Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? Curr Atheroscler Rep. 2011 Feb; 13(1):31-42. PMID: 21046291; PMCID: PMC3018293.
    96. Gower RM, Wu H, Foster GA, Devaraj S, Jialal I, Ballantyne CM, Knowlton AA, Simon SI. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2011 Jan; 31(1):160-6. PMID: 21030716; PMCID: PMC3038249.
    97. Dasu MR, Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab. 2011 Jan; 300(1):E145-54. PMID: 20959532; PMCID: PMC3023203.
    98. Jialal I, Fadini GP, Pollock K, Devaraj S. Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome. Am J Cardiol. 2010 Dec 01; 106(11):1606-8. PMID: 21040691; PMCID: PMC3052293.
    99. Dasu MR, Thangappan RK, Bourgette A, DiPietro LA, Isseroff R, Jialal I. TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice. Lab Invest. 2010 Nov; 90(11):1628-36. PMID: 20733560.
      View in: PubMed
    100. Devaraj S, Duncan-Staley C, Jialal I. Evaluation of a method for fibroblast growth factor-23: a novel biomarker of adverse outcomes in patients with renal disease. Metab Syndr Relat Disord. 2010 Dec; 8(6):477-82. PMID: 20707671; PMCID: PMC3125567.
    101. Jialal I, Amess W, Kaur M. Management of hypertriglyceridemia in the diabetic patient. Curr Diab Rep. 2010 Aug; 10(4):316-20. PMID: 20532703; PMCID: PMC2890983.
    102. Raychaudhuri SK, Chatterjee S, Nguyen C, Kaur M, Jialal I, Raychaudhuri SP. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord. 2010 Aug; 8(4):331-4. PMID: 20367239; PMCID: PMC3129701.
    103. Yun JM, Jialal I, Devaraj S. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. 2011 May; 22(5):450-8. PMID: 20655188; PMCID: PMC3010508.
    104. Yun JM, Singh S, Jialal R, Rockwood J, Jialal I, Devaraj S. A randomized placebo-controlled crossover trial of aloe vera on bioavailability of vitamins C and B(12), blood glucose, and lipid profile in healthy human subjects. J Diet Suppl. 2010 Jun; 7(2):145-53. PMID: 22435613.
      View in: PubMed
    105. Jialal I. Endothelial progenitor cell status in metabolic syndrome. Metab Syndr Relat Disord. 2010 Jun; 8(3):193-5. PMID: 20367241.
      View in: PubMed
    106. Valleggi S, Devaraj S, Dasu MR, Jialal I. C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase. Clin Chem. 2010 Aug; 56(8):1345-8. PMID: 20472823.
      View in: PubMed
    107. Devaraj S, Valleggi S, Siegel D, Jialal I. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep. 2010 Mar; 12(2):110-8. PMID: 20425246; PMCID: PMC2854398.
    108. Yun JM, Jialal I, Devaraj S. Effects of epigallocatechin gallate on regulatory T cell number and function in obese v. lean volunteers. Br J Nutr. 2010 Jun; 103(12):1771-7. PMID: 20175943.
      View in: PubMed
    109. Devaraj S, Jialal I, Yun JM, Bremer A. Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism. 2011 Feb; 60(2):256-9. PMID: 20153491; PMCID: PMC2891423.
    110. Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010 Apr; 33(4):861-8. PMID: 20067962; PMCID: PMC2845042.
    111. Devaraj S, Dasu MR, Jialal I. Diabetes is a proinflammatory state: a translational perspective. Expert Rev Endocrinol Metab. 2010 Jan 01; 5(1):19-28. PMID: 20204165.
      View in: PubMed
    112. Jialal I, Devaraj S. Statin therapy for the metabolic syndrome: the evidence base. Metab Syndr Relat Disord. 2009 Oct; 7(5):393-6. PMID: 19731996.
      View in: PubMed
    113. Jialal I. The role of the laboratory in the diagnosis of the metabolic syndrome. Am J Clin Pathol. 2009 Aug; 132(2):161-2. PMID: 19605808.
      View in: PubMed
    114. Jialal I, Devaraj S. Lipid management in clinical practice. Curr Opin Lipidol. 2009 Aug; 20(4):350-2. PMID: 19584593.
      View in: PubMed
    115. Devaraj S, Yun JM, Adamson G, Galvez J, Jialal I. C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res. 2009 Dec 01; 84(3):479-84. PMID: 19620133; PMCID: PMC2777951.
    116. Jialal I, Abby SL, Misir S, Nagendran S. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis. Metab Syndr Relat Disord. 2009 Jun; 7(3):255-8. PMID: 19344229; PMCID: PMC3135892.
    117. Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009 Jun; 20(3):182-9. PMID: 19369869; PMCID: PMC2921825.
    118. Devaraj S, Jialal I. Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway. Cytokine. 2009 Jul; 47(1):6-10. PMID: 19447045; PMCID: PMC2771557.
    119. Dasu MR, Park S, Devaraj S, Jialal I. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology. 2009 Aug; 150(8):3457-64. PMID: 19389833; PMCID: PMC2717888.
    120. Bajaj M, Jialal I. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé. Metab Syndr Relat Disord. 2009 Apr; 7(2):79-81. PMID: 19351292.
      View in: PubMed
    121. Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I. Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis. 2009 Sep; 206(1):61-8. PMID: 19268941; PMCID: PMC2735606.
    122. Jialal I, Bajaj M. Therapy and clinical trials: management of diabetic dyslipidemia. Curr Opin Lipidol. 2009 Feb; 20(1):85-6. PMID: 19106714; PMCID: PMC2662848.
    123. Devaraj S, Singh U, Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem. 2009 Feb; 55(2):229-38. PMID: 19095731; PMCID: PMC2662846.
    124. Jialal I, Verma S, Devaraj S. Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance. Clin Chem. 2009 Feb; 55(2):206-8. PMID: 19095724; PMCID: PMC2662849.
    125. Singh U, Devaraj S, Jialal I. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Clin Chem. 2009 Feb; 55(2):361-4. PMID: 19074520; PMCID: PMC2662851.
    126. Devaraj S, Yun JM, Duncan-Staley C, Jialal I. C-reactive protein induces M-CSF release and macrophage proliferation. J Leukoc Biol. 2009 Feb; 85(2):262-7. PMID: 19008293; PMCID: PMC2631367.
    127. Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev. 2008 Nov; 66(11):646-57. PMID: 19019027; PMCID: PMC2657658.
    128. Devaraj S, Jialal I. Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity. Arch Pathol Lab Med. 2008 Sep; 132(9):1432-5. PMID: 18788855; PMCID: PMC2662847.
    129. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008 Nov; 57(11):3090-8. PMID: 18650365; PMCID: PMC2570406.
    130. Devaraj S, Dasu MR, Singh U, Rao LV, Jialal I. C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis. 2009 Mar; 203(1):67-74. PMID: 18621373; PMCID: PMC2649999.
    131. Wang L, Rockwood J, Zak D, Devaraj S, Jialal I. Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome. Metab Syndr Relat Disord. 2008 Jun; 6(2):149-52. PMID: 18484901; PMCID: PMC2692921.
    132. Devaraj S, Wang-Polagruto J, Polagruto J, Keen CL, Jialal I. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism. 2008 Jun; 57(6):867-70. PMID: 18502272; PMCID: PMC2692901.
    133. Singh U, Devaraj S, Jialal I, Siegel D. Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome. Am J Cardiol. 2008 Aug 01; 102(3):321-5. PMID: 18638594; PMCID: PMC2676172.
    134. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008 Jul; 28(7):1368-74. PMID: 18451326; PMCID: PMC2771588.
    135. Devaraj S, Swarbrick MM, Singh U, Adams-Huet B, Havel PJ, Jialal I. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am J Clin Pathol. 2008 May; 129(5):815-22. PMID: 18426744; PMCID: PMC2664630.
    136. Dasu MR, Riosvelasco AC, Jialal I. Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo. Atherosclerosis. 2009 Jan; 202(1):76-83. PMID: 18495130; PMCID: PMC2676176.
    137. Devaraj S, Mathur S, Basu A, Aung HH, Vasu VT, Meyers S, Jialal I. A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. J Am Coll Nutr. 2008 Apr; 27(2):267-73. PMID: 18689558; PMCID: PMC2677959.
    138. Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med. 2008 Mar 15; 44(6):1203-8. PMID: 18191645; PMCID: PMC2676174.
    139. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 2008 Feb; 93(2):578-83. PMID: 18029454; PMCID: PMC2243229.
    140. Devaraj S, Tang R, Adams-Huet B, Harris A, Seenivasan T, de Lemos JA, Jialal I. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr. 2007 Nov; 86(5):1392-8. PMID: 17991651.
      View in: PubMed
    141. Jialal I, Devaraj S. Statin therapy in acute cardiovascular syndromes. Curr Opin Lipidol. 2007 Oct; 18(5):610-2. PMID: 17885436.
      View in: PubMed
    142. Singh U, Devaraj S, Vasquez-Vivar J, Jialal I. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol. 2007 Dec; 43(6):780-91. PMID: 17942113; PMCID: PMC2771555.
    143. Devaraj S, Siegel D, Jialal I. Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome. Am J Cardiol. 2007 Nov 01; 100(9):1397-9. PMID: 17950796; PMCID: PMC2080663.
    144. Devaraj S, Cheung AT, Jialal I, Griffen SC, Nguyen D, Glaser N, Aoki T. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes. 2007 Nov; 56(11):2790-6. PMID: 17686944; PMCID: PMC2692935.
    145. Jialal I, Devaraj S. Therapy and clinical trials. Curr Opin Lipidol. 2007 Aug; 18(4):479-81. PMID: 17620868; PMCID: PMC2677957.
    146. Singh U, Devaraj S, Jialal I. Coenzyme Q10 supplementation and heart failure. Nutr Rev. 2007 Jun; 65(6 Pt 1):286-93. PMID: 17605305.
      View in: PubMed
    147. Jialal I, Miguelino E, Griffen SC, Devaraj S. Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes. J Clin Endocrinol Metab. 2007 Aug; 92(8):3136-40. PMID: 17519305; PMCID: PMC2677961.
    148. Lakshminarayanan R, Li Y, Janatpour K, Beckett L, Jialal I. Detection by immunofixation of M proteins in hypogammaglobulinemic patients with normal serum protein electrophoresis results. Am J Clin Pathol. 2007 May; 127(5):746-51. PMID: 17439833.
      View in: PubMed
    149. Dasu MR, Devaraj S, Jialal I. High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab. 2007 Jul; 293(1):E337-46. PMID: 17426109; PMCID: PMC2676171.
    150. Singh U, Otvos J, Dasgupta A, de Lemos JA, Devaraj S, Jialal I. High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy. Clin Chem. 2007 Mar; 53(3):525-8. PMID: 17234730.
      View in: PubMed
    151. Jialal I. Editorial. Metab Syndr Relat Disord. 2007; 5(1):1-2. PMID: 18370808.
      View in: PubMed
    152. Devaraj S, Rogers J, Jialal I. Statins and biomarkers of inflammation. Curr Atheroscler Rep. 2007 Jan; 9(1):33-41. PMID: 17169243.
      View in: PubMed
    153. Jialal I, Devaraj S. The role of C-reactive protein activation of nuclear factor kappa-B in the pathogenesis of unstable angina. J Am Coll Cardiol. 2007 Jan 16; 49(2):195-7. PMID: 17222730.
      View in: PubMed
    154. Dasu MR, Devaraj S, Du Clos TW, Jialal I. The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J Lipid Res. 2007 Mar; 48(3):509-12. PMID: 17158793.
      View in: PubMed
    155. Jialal I. Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis. Crit Pathw Cardiol. 2006 Dec; 5(4):191-210. PMID: 18340237.
      View in: PubMed
    156. Devaraj S, Kasim-Karakas S, Jialal I. The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep. 2006 Nov; 8(6):477-86. PMID: 17045074.
      View in: PubMed
    157. Devaraj S, Autret BC, Jialal I. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am J Clin Nutr. 2006 Oct; 84(4):756-61. PMID: 17023701.
      View in: PubMed
    158. Devaraj S, Chan E, Jialal I. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab. 2006 Nov; 91(11):4489-96. PMID: 16968805.
      View in: PubMed
    159. Singh U, Devaraj S, Dasu MR, Ciobanu D, Reusch J, Jialal I. C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler Thromb Vasc Biol. 2006 Nov; 26(11):2469-75. PMID: 16917108.
      View in: PubMed
    160. Kitsis RN, Jialal I. Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein. N Engl J Med. 2006 Aug 03; 355(5):513-5. PMID: 16885557.
      View in: PubMed
    161. Devaraj S, Autret B, Jialal I. Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia. Am J Cardiol. 2006 Sep 01; 98(5):641-3. PMID: 16923452.
      View in: PubMed
    162. Devaraj S, Jialal I. The role of dietary supplementation with plant sterols and stanols in the prevention of cardiovascular disease. Nutr Rev. 2006 Jul; 64(7 Pt 1):348-54. PMID: 16910223.
      View in: PubMed
    163. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology. 2006 Aug; 13(3):129-42. PMID: 16757157.
      View in: PubMed
    164. Verma S, Devaraj S, Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006 May 02; 113(17):2135-50; discussion 2150. PMID: 16671184.
      View in: PubMed
    165. Devaraj S, Davis B, Simon SI, Jialal I. CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol. 2006 Sep; 291(3):H1170-6. PMID: 16603696.
      View in: PubMed
    166. Zhang YH, Huang BL, Jialal I, Northrup H, McCabe ER, Dipple KM. Asymptomatic isolated human glycerol kinase deficiency associated with splice-site mutations and nonsense-mediated decay of mutant RNA. Pediatr Res. 2006 Apr; 59(4 Pt 1):590-2. PMID: 16549535.
      View in: PubMed
    167. Jialal I, Devaraj S, Singh U. C-reactive protein and the vascular endothelium: implications for plaque instability. J Am Coll Cardiol. 2006 Apr 04; 47(7):1379-81. PMID: 16580525.
      View in: PubMed
    168. Jialal I, Singh U. Is vitamin C an antiinflammatory agent? Am J Clin Nutr. 2006 Mar; 83(3):525-6. PMID: 16522896.
      View in: PubMed
    169. Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006 Mar; 55(3):774-9. PMID: 16505242.
      View in: PubMed
    170. Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol. 2006 May; 26(5):995-1001. PMID: 16484595.
      View in: PubMed
    171. Devaraj S, Venugopal S, Jialal I. Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis. 2006 Jan; 184(1):48-52. PMID: 15894319.
      View in: PubMed
    172. Chandalia M, Jialal I. Therapy and clinical trials. Curr Opin Lipidol. 2005 Dec; 16(6):708-10. PMID: 16276251.
      View in: PubMed
    173. Singh U, Tabibian J, Venugopal SK, Devaraj S, Jialal I. Development of an in vitro screening assay to test the antiinflammatory properties of dietary supplements and pharmacologic agents. Clin Chem. 2005 Dec; 51(12):2252-6. PMID: 16166164.
      View in: PubMed
    174. Singh U, Devaraj S, Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2216-21. PMID: 16123325.
      View in: PubMed
    175. Devaraj S, Jialal I. Failure of vitamin E in clinical trials: is gamma-tocopherol the answer? Nutr Rev. 2005 Aug; 63(8):290-3. PMID: 16190316.
      View in: PubMed
    176. Jialal I, Devaraj S. High-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med. 2005 Jul 19; 143(2):155; author reply 156-8. PMID: 16027470.
      View in: PubMed
    177. Devaraj S, O'Keefe G, Jialal I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab. 2005 Aug; 90(8):4549-54. PMID: 15899961.
      View in: PubMed
    178. Devaraj S, Jialal I. Alpha-tocopherol decreases tumor necrosis factor-alpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase. Free Radic Biol Med. 2005 May 01; 38(9):1212-20. PMID: 15808419.
      View in: PubMed
    179. Devaraj S, Du Clos TW, Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1359-63. PMID: 15860734.
      View in: PubMed
    180. Hathcock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, Jialal I, Johnston CS, Kelly FJ, Kraemer K, Packer L, Parthasarathy S, Sies H, Traber MG. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. 2005 Apr; 81(4):736-45. PMID: 15817846.
      View in: PubMed
    181. Venugopal SK, Devaraj S, Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol. 2005 Apr; 166(4):1265-71. PMID: 15793305; PMCID: PMC1602373.
    182. Dietrich M, Jialal I. The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev. 2005 Jan; 63(1):22-8. PMID: 15730232.
      View in: PubMed
    183. Devaraj S, Venugopal SK, Singh U, Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes. 2005 Jan; 54(1):85-91. PMID: 15616014.
      View in: PubMed
    184. Vega-López S, Yeum KJ, Lecker JL, Ausman LM, Johnson EJ, Devaraj S, Jialal I, Lichtenstein AH. Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones. Am J Clin Nutr. 2005 Jan; 81(1):43-9. PMID: 15640458.
      View in: PubMed
    185. Venugopal SK, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens. 2005 Jan; 14(1):33-7. PMID: 15586013.
      View in: PubMed
    186. Singh U, Jialal I. Anti-inflammatory effects of alpha-tocopherol. Ann N Y Acad Sci. 2004 Dec; 1031:195-203. PMID: 15753145.
      View in: PubMed
    187. Packer L, Blumberg J, Jialal I, Lunec J, Meydani S, Violi F, Willett W. Future directions in clinical vitamin E research: panel discussion B. Ann N Y Acad Sci. 2004 Dec; 1031:313-23. PMID: 15753157.
      View in: PubMed
    188. Stauffenberg MT, Lange RA, Hillis LD, Cigarroa J, Hsu RM, Devaraj S, Jialal I. Hyperhomocysteinemia measured by immunoassay: a valid measure of coronary artery atherosclerosis. Arch Pathol Lab Med. 2004 Nov; 128(11):1263-6. PMID: 15504061.
      View in: PubMed
    189. Venugopal SK, Devaraj S, Jialal I. RRR-alpha-tocopherol decreases the expression of the major scavenger receptor, CD36, in human macrophages via inhibition of tyrosine kinase (Tyk2). Atherosclerosis. 2004 Aug; 175(2):213-20. PMID: 15262176.
      View in: PubMed
    190. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, Lindberg GM, Jialal I, Munford RS, O'Keefe GE. Innate immunity genes influence the severity of acute appendicitis. Ann Surg. 2004 Aug; 240(2):269-77. PMID: 15273551; PMCID: PMC1356403.
    191. Abbas A, Fadel PJ, Wang Z, Arbique D, Jialal I, Vongpatanasin W. Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women. Arterioscler Thromb Vasc Biol. 2004 Oct; 24(10):e164-7. PMID: 15284085.
      View in: PubMed
    192. Devaraj S, Rosenson RS, Jialal I. Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinol Metab Clin North Am. 2004 Jun; 33(2):431-53, table of contents. PMID: 15158528.
      View in: PubMed
    193. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. 2004 Jul; 44(1):6-11. PMID: 15148294.
      View in: PubMed
    194. Devaraj S, Kumaresan PR, Jialal I. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol. 2004 Mar; 36(3):405-10. PMID: 15010279.
      View in: PubMed
    195. Devaraj S, Jialal I, Vega-López S. Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholesterolemic healthy individuals. Arterioscler Thromb Vasc Biol. 2004 Mar; 24(3):e25-8. PMID: 14764424.
      View in: PubMed
    196. Vega-López S, Kaul N, Devaraj S, Cai RY, German B, Jialal I. Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism. 2004 Feb; 53(2):236-40. PMID: 14767877.
      View in: PubMed
    197. Vega-López S, Devaraj S, Jialal I. Oxidative stress and antioxidant supplementation in the management of diabetic cardiovascular disease. J Investig Med. 2004 Jan; 52(1):24-32. PMID: 14989367.
      View in: PubMed
    198. Jialal I, Kappagoda T. Therapy and clinical trials: ezetimibe. Curr Opin Lipidol. 2003 Dec; 14(6):643-6. PMID: 14624143.
      View in: PubMed
    199. Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation. 2003 Oct 07; 108(14):1676-8. PMID: 14504187.
      View in: PubMed
    200. Chandalia M, Cabo-Chan AV, Devaraj S, Jialal I, Grundy SM, Abate N. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab. 2003 Aug; 88(8):3773-6. PMID: 12915668.
      View in: PubMed
    201. Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol. 2003 Apr 16; 41(8):1358-63. PMID: 12706932.
      View in: PubMed
    202. Narayan S, Lujan MG, Baskin LB, Devaraj S, Rutherford C, Jialal I. Measurement of beta1- and beta2-globulins improves detection of M-spikes on high-resolution electrophoresis. Clin Chem. 2003 Apr; 49(4):676-8. PMID: 12651829.
      View in: PubMed
    203. Jialal I, Berglund L. Therapy and clinical trials. Curr Opin Lipidol. 2003 Apr; 14(2):227-30. PMID: 12642792.
      View in: PubMed
    204. Chandalia M, Abate N, Cabo-Chan AV, Devaraj S, Jialal I, Grundy SM. Hyperhomocysteinemia in Asian Indians living in the United States. J Clin Endocrinol Metab. 2003 Mar; 88(3):1089-95. PMID: 12629089.
      View in: PubMed
    205. Hirany SV, Othman Y, Kutscher P, Rainwater DL, Jialal I, Devaraj S. Comparison of low-density lipoprotein size by polyacrylamide tube gel electrophoresis and polyacrylamide gradient gel electrophoresis. Am J Clin Pathol. 2003 Mar; 119(3):439-45. PMID: 12669713.
      View in: PubMed
    206. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003 Jan 28; 107(3):398-404. PMID: 12551862.
      View in: PubMed
    207. Jialal I, Devaraj S. Role of C-reactive protein in the assessment of cardiovascular risk. Am J Cardiol. 2003 Jan 15; 91(2):200-2. PMID: 12521635.
      View in: PubMed
    208. O'Byrne DJ, Devaraj S, Grundy SM, Jialal I. Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr. 2002 Dec; 76(6):1367-74. PMID: 12450905.
      View in: PubMed
    209. Mathur S, Devaraj S, Grundy SM, Jialal I. Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J Nutr. 2002 Dec; 132(12):3663-7. PMID: 12468604.
      View in: PubMed
    210. Devaraj S, Vega-López S, Kaul N, Schönlau F, Rohdewald P, Jialal I. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids. 2002 Oct; 37(10):931-4. PMID: 12530550.
      View in: PubMed
    211. Venugopal SK, Devaraj S, Yang T, Jialal I. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes. 2002 Oct; 51(10):3049-54. PMID: 12351446.
      View in: PubMed
    212. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002 Sep 17; 106(12):1439-41. PMID: 12234944.
      View in: PubMed
    213. Harris A, Devaraj S, Jialal I. Oxidative stress, alpha-tocopherol therapy, and atherosclerosis. Curr Atheroscler Rep. 2002 Sep; 4(5):373-80. PMID: 12162937.
      View in: PubMed
    214. Abate N, Jialal I. Therapy and clinical trials. Curr Opin Lipidol. 2002 Aug; 13(4):457-60. PMID: 12151863.
      View in: PubMed
    215. Bonow RO, Mitch WE, Nesto RW, O'Gara PT, Becker RC, Clark LT, Hunt S, Jialal I, Lipshultz SE, Loh E. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications. Circulation. 2002 May 07; 105(18):e159-64. PMID: 11994267.
      View in: PubMed
    216. Devaraj S, Chan AV, Jialal I. alpha-Tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients. Diabetes Care. 2002 Mar; 25(3):524-9. PMID: 11874941.
      View in: PubMed
    217. Mathur S, Devaraj S, Jialal I. Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease. Curr Opin Nephrol Hypertens. 2002 Mar; 11(2):141-7. PMID: 11856905.
      View in: PubMed
    218. Hsu RM, Devaraj S, Jialal I. Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus. Clin Chim Acta. 2002 Mar; 317(1-2):145-50. PMID: 11814469.
      View in: PubMed
    219. Miller M, Jialal I. Effects of simvastatin (40 and 80 mg) on highly sensitive C-reactive protein in patients with combined hyperlipidemia. Am J Cardiol. 2002 Feb 15; 89(4):468-9. PMID: 11835933.
      View in: PubMed
    220. Jialal I, Devaraj S. Remnant lipoproteins: measurement and clinical significance. Clin Chem. 2002 Feb; 48(2):217-9. PMID: 11805002.
      View in: PubMed
    221. Devaraj S, Harris A, Jialal I. Modulation of monocyte-macrophage function with alpha-tocopherol: implications for atherosclerosis. Nutr Rev. 2002 Jan; 60(1):8-14. PMID: 11843003.
      View in: PubMed